Naturally occurring molecule suppresses appetite and promotes weight loss

FHS
March 6, 2025
5:33 am

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide – also known as Ozempic – in suppressing appetite and reducing body weight.

Apnimed, a late-stage sleep apnea biotech, eyes IPO in the second half

Apnimed, which has a novel sleep apnea drug in Phase III, is considering a potential IPO in the second half of this year even as

February 16, 2024

Natural nutrients nicotinamide and pyridoxine reverse muscle aging

Researchers identified nicotinamide (NAM) and pyridoxine (PN) as safe, synergistic nutrients that restore muscle stem cell function, reversing age-related muscle degeneration in mice and humans.

December 18, 2024

Opinion | ‘Safe and Effective’ Is FDA-Speak. It’s Time to Put It to Bed.

Gorman, Lanthorn, Rabin, and Ratzan are founders of an organization that advocates for accurate, responsible, clear, and culturally sensitive health communication. Many people today think

January 29, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.